Balance Sheet Breakdown: Geron Corp. (GERN)’s Debt-to-Equity and Long-Term Debt/Eq Ratios

Investors on the quest for market-beating returns often employ the strategy of stock picking. Making informed choices in stocks can greatly amplify your wealth.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

After finishing at $4.40 in the prior trading day, Geron Corp. (NASDAQ: GERN) closed at $4.29, down -2.50%. In other words, the price has decreased by -$2.50 from its previous closing price. On the day, 7.64 million shares were traded. GERN stock price reached its highest trading level at $4.39 during the session, while it also had its lowest trading level at $4.24.

Ratios:

Our goal is to gain a better understanding of GERN by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 3.60 and its Current Ratio is at 3.61. In the meantime, Its Debt-to-Equity ratio is 0.28 whereas as Long-Term Debt/Eq ratio is at 0.13.

On April 29, 2024, TD Cowen started tracking the stock assigning a Buy rating and target price of $10.

Needham reiterated its Buy rating for the stock on March 15, 2024, while the target price for the stock was revised from $4 to $5.

Insider Transactions:

The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jul 08 ’24 when GRETHLEIN ANDREW J sold 674,348 shares for $4.56 per share. The transaction valued at 3,073,004 led to the insider holds 0 shares of the business.

Feller Faye sold 287,900 shares of GERN for $1,334,129 on Jun 10 ’24. The EVP, Chief Medical Officer now owns 0 shares after completing the transaction at $4.63 per share. On Jun 10 ’24, another insider, Kapur Anil, who serves as the EVP, Corp Strategy & CCO of the company, sold 421,875 shares for $4.64 each. As a result, the insider received 1,959,609 and left with 0 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, GERN now has a Market Capitalization of 2652301312 and an Enterprise Value of 2376608512. For the stock, the TTM Price-to-Sale (P/S) ratio is 1887.60 while its Price-to-Book (P/B) ratio in mrq is 8.41. Its current Enterprise Value per Revenue stands at 1730.96 whereas that against EBITDA is -10.48.

Stock Price History:

Over the past 52 weeks, GERN has reached a high of $5.34, while it has fallen to a 52-week low of $1.64. The 50-Day Moving Average of the stock is -6.13%, while the 200-Day Moving Average is calculated to be 31.63%.

Shares Statistics:

The stock has traded on average 12.02M shares per day over the past 3-months and 7836120 shares per day over the last 10 days, according to various share statistics. A total of 602.80M shares are outstanding, with a floating share count of 551.80M. Insiders hold about 8.46% of the company’s shares, while institutions hold 69.60% stake in the company. Shares short for GERN as of 1723680000 were 69108061 with a Short Ratio of 5.75, compared to 1721001600 on 44657819. Therefore, it implies a Short% of Shares Outstanding of 69108061 and a Short% of Float of 11.53.

Most Popular